A COMPREHENSIVE REVIEW: STUDY ON SCIENTIFIC VALIDATION OF AYURVEDIC MARKETED FORMULATIONS

A COMPREHENSIVE REVIEW: STUDY ON SCIENTIFIC VALIDATION OF AYURVEDIC MARKETED FORMULATIONS

Deepali Kashayap *, Pushpendra Kannojia and Prashant Kumar Sharma

BIU College of Pharmacy, Bareilly International University, Bareilly, Uttar Pradesh, India.

ABSTRACT: One of the earliest traditional medical systems, Ayurveda, has become well-known around the world for its extensive use of herbal formulations and holistic treatment approach. Concerns about quality, safety, effectiveness, repeatability, and standardisation continue to be significant obstacles despite the growing commercialisation of Ayurvedic goods. Therefore, in order to prove the legitimacy of commercialised Ayurvedic medicines in contemporary healthcare systems, scientific validation has become crucial. Pharmacognostic evaluation, phytochemical screening, chromatographic profiling, physicochemical analysis, toxicity assessment, pharmacological investigations, and clinical validation are among the methods now employed in the scientific validation of Ayurvedic formulations that are included in this study. The paper also emphasises quality control methods, contemporary analytical techniques, regulatory frameworks, and difficulties in standardising polyherbal formulations. Integration of traditional Ayurvedic principles with modern scientific methodologies is necessary to ensure safety, efficacy, consistency, and global acceptance of Ayurvedic medicines.

Keywords: Ayurveda, Scientific validation, Standardization, Polyherbal formulations, Quality control, Herbal medicines, Phytochemical analysis, Clinical evaluation

INTRODUCTION: The development of Ayurveda, Unani, Siddha, homoeopathy, and other natural herb-based health sciences originated in India (Ayush). The Ayush pharmaceutical sector has enormous potential and future growth prospects ¹. These include Ayurvedic medicines, Unani medicines, Siddha medicines, homoeopathic medicines, herbal nutraceuticals, herbal cosmoceuticals, herbal health drinks, dietary health supplements, medicinal plants and crude drugs, herbal extracts and concentrates, herbal veterinary medicines, health foods, Ayush health care management, Ayurvedic panchakarma centers, and health spas.

In India, the Ayurvedic philosophy emerged and evolved between 2500 and 500 BC ². The actual definition of Ayurveda is “science of life,” because ancient Indian system of health treatment centred on perspectives of man and his ailment. It has been noted that people in good health are metabolically balanced. Because it provides a comprehensive approach for living a long, healthy life, Ayurveda is often known as the "science of longevity." It provides nutrition and diet regimens to revitalise the body. It provides therapies for a number of common illnesses, including food allergies, for which there are currently few effective treatments.

But it's important to understand that Ayurvedic diet is not a "magic bullet" approach; rather, its success depends on the patient's complete involvement. It is an instructive and user-friendly interactive system. It educates the patient how to take charge of their own destiny. Ayurveda is not a diet plan for people looking for a way out or a justification to continue abusing their bodies or minds. It is a system of long life, independence, and empowerment ³. Ayurvedic formulations, which include churna, kwatha, arishta, avaleha, vati, and ghrita, are often made from medicinal herbs, minerals, and animal products.

Because of their natural nature and perceived safety, Ayurvedic medicines have seen a significant surge in demand worldwide in recent decades ⁴. Concerns about adulteration, contamination, batch-to-batch variance, a lack of scientific proof, and variable therapeutic results have also been raised by the commercialisation of Ayurvedic medicines. For marketed Ayurvedic goods to be authentic, high-quality, safe, and effective, scientific validation is consequently required ⁵.

Ayurvedic remedies are gradually being validated and standardised using contemporary scientific methods including chromatography, spectroscopy, metabolomics, pharmacological research, and clinical trials. Standardisation ensures repeatable therapeutic effects while preserving uniformity in raw materials, production processes, and final goods ⁶.

Need for Scientific Validation of Ayurvedic Formulations: Scientific validation is essential for the following reasons:

• To ensure safety and efficacy of formulations.
• To prevent adulteration and contamination.
• To establish quality standards.
• To achieve reproducibility and batch consistency.
• To gain international acceptance.
• To support evidence-based medicine.
• To comply with regulatory requirements ^{7, 8}.

Ayurvedic Formulations: Ayurveda formulations are medicinal preparations prepared according to Ayurvedic principles using herbs, minerals, metals, animal products, or combinations of these ingredients. These formulations are designed to restore balance among the three doshas - Vata, Pitta, & Kapha and are used for prevention and treatment of diseases ⁹.

TABLE 1: AYURVEDIC FORMULATIONS AND THEIR PHARMACEUTICAL PREPARATIONS ^11-22

Scientific Approaches for Validation:

Pharmacognostic Evaluation: Pharmacognostic studies are the preliminary steps in herbal drug standardization. These methods help in identification and authentication of crude drugs and detection of adulterants.

TABLE 2: PHARMACOGNOSTIC EVALUATION TECHNIQUES USED IN SCIENTIFIC VALIDATION OF AYURVEDIC FORMULATIONS ^23-27

Physicochemical Evaluation: Physicochemical parameters are important quality indicators for Ayurvedic formulations. These parameters help maintain quality consistency and shelf-life stability.

TABLE 3: PHYSICOCHEMICAL EVALUATION PARAMETERS USED IN SCIENTIFIC VALIDATION OF AYURVEDIC FORMULATIONS ^25-30

Phytochemical Screening: Preliminary phytochemical analysis identifies active constituents such as Alkaloids, Flavonoids, Glycosides, Tannins, Saponins, Terpenoids and Phenolic compounds. Phytochemical studies provide information regarding bioactive constituents responsible for therapeutic activity.

TABLE 4: MAJOR PHYTOCHEMICAL CONSTITUENTS IN AYURVEDIC FORMULATIONS ^31-33

Modern Analytical Techniques Used in Validation: Advanced analytical tools are widely employed for scientific validation and quality control of Ayurvedic formulations.

Chromatographic Techniques: Modern analytical chemistry plays a significant role in characterization and quality assurance of Ayurvedic preparations.

Thin Layer Chromatography (TLC): Used for identification and fingerprint profiling of herbal constituents.

High Performance Thin Layer Chromatography (HPTLC): Provides accurate qualitative and quantitative estimation of phytoconstituents.

High Performance Liquid Chromatography (HPLC): Used for separation, quantification, and standardization of marker compounds.

Gas Chromatography–Mass Spectrometry (GC-MS): Useful for volatile compound analysis and metabolite identification.

Liquid Chromatography–Mass Spectrometry (LC-MS): Provides detailed molecular profiling and metabolomics data ^34-36.

Spectroscopic Techniques: These techniques are useful for structural characterization and detection of heavy metals or contaminants. Common spectroscopic methods include:

• UV-Visible Spectroscopy
• FTIR Spectroscopy
• NMR Spectroscopy
• Atomic Absorption Spectroscopy ^36-39.

Toxicological Evaluation: Safety assessment is an important component of scientific validation.

TABLE 5: TOXICOLOGICAL EVALUATION OF AYURVEDIC FORMULATIONS ^40-42

Pharmacological Validation: Pharmacological studies evaluate biological activity using experimental models.

TABLE 6: MAJOR PHARMACOLOGICAL ACTIVITIES STUDIED IN AYURVEDIC FORMULATIONS ^{40, 43-46}

Recent studies have demonstrated significant therapeutic potential of several Ayurvedic formulations using in-vitro and in-vivo experimental models.

Clinical Validation: Clinical trials are considered the gold standard for evaluating efficacy and safety in humans.

Clinical Validation Includes ^47-50:

Randomized Controlled Trials (RCTs): Randomized controlled trials are considered the gold standard for evaluating the efficacy and safety of Ayurvedic formulations. In this method, participants are randomly assigned into different groups, such as treatment and control groups, to minimize bias and ensure reliable results. The treatment group receives the Ayurvedic formulation under investigation, while the control group may receive a placebo, standard treatment, or no treatment. Randomization and blinding techniques improve the scientific validity of the study. RCTs help determine therapeutic effectiveness, dosage accuracy, adverse effects, and clinical outcomes under controlled conditions.

Observational Studies: Observational studies involve monitoring patients receiving Ayurvedic treatments without manipulating the intervention or assigning participants randomly. Researchers collect clinical data regarding disease progression, treatment outcomes, safety, and patient responses in real-world settings. These studies may be prospective or retrospective and are useful for understanding long-term effectiveness, patient compliance, and patterns of use in large populations. Observational studies are particularly important in Ayurveda because they help evaluate traditional practices and individualized therapies under routine clinical conditions.

Comparative Clinical Studies: Comparative clinical studies are designed to compare the effectiveness and safety of Ayurvedic formulations with other treatments, such as allopathic medicines, placebo therapies, or different Ayurvedic preparations. These studies help identify the relative therapeutic benefits, side effects, cost-effectiveness, and patient acceptability of different treatment modalities. Comparative studies provide valuable evidence regarding whether Ayurvedic formulations offer equivalent or superior clinical outcomes compared to conventional therapies for specific diseases or conditions.

Pharmacovigilance Studies: Pharmacovigilance studies focus on the detection, assessment, monitoring, and prevention of adverse effects associated with Ayurvedic formulations. These studies collect information related to side effects, drug interactions, toxicity, allergic reactions, and medication errors during clinical use.

Pharmacovigilance is essential for ensuring the long-term safety of Ayurvedic medicines, especially herbo-mineral formulations and polyherbal preparations. Continuous monitoring helps regulatory authorities and healthcare professionals identify potential risks, improve patient safety, and establish evidence-based guidelines for the safe use of Ayurvedic products. Clinical evidence strengthens acceptance of Ayurvedic formulations in mainstream healthcare systems. However, limitations such as small sample sizes, inadequate blinding, poor study design, and lack of multicentric trials still affect the quality of evidence.

Regulatory Framework for Ayurvedic Formulations: In India, Ayurvedic drugs are regulated under ^51-53:

Drugs and Cosmetics Act, 1940: The main law controlling the production, sale, distribution, and quality assurance of Ayurvedic, Siddha, and Unani medicines in India is the Drugs and Cosmetics Act, 1940. The Act creates legal requirements to guarantee traditional medical items' purity, safety, and effectiveness. This Act contains specific regulations that govern Ayurvedic formulation production procedures, storage conditions, labelling standards, and licensing requirements. Additionally, it gives regulatory bodies the ability to keep an eye on counterfeit goods, misbranding, and adulteration. The Act provides the legislative framework for controlling the Ayurvedic pharmaceutical sector and safeguarding public health.

Ministry of AYUSH Guidelines: The Government of India's Ministry of AYUSH is in charge of promoting, regulating, teaching, and researching traditional medical systems, such as Ayurveda.

The ministry publishes thorough recommendations on pharmacovigilance, clinical research, quality control, raw material procurement, manufacturing standards, and Ayurvedic formulation standardisation. These rules support the preservation of consistency and scientific validity in Ayurvedic industry and practices. In order to promote evidence-based Ayurveda and the acceptability of traditional medical systems across the world, the Ministry also funds research projects, digitalisation, and international cooperation.

Ayurvedic Pharmacopoeia of India (API): An official document that offers uniform quality standards for Ayurvedic medications and formulations is the Ayurvedic Pharmacopoeia of India (API). It contains comprehensive monographs on the identification, strength, purity, analytical techniques, physicochemical characteristics, and quality standards of Ayurvedic medicinal herbs and formulations.

For producers, researchers, regulatory bodies, and quality control labs, the API is a reliable resource. The API guarantees the uniformity, authenticity, and safety of Ayurvedic raw materials and completed goods by setting criteria that have been scientifically established.

Good Manufacturing Practices (GMP): Ayurvedic medicines are routinely made and monitored in accordance with predetermined quality standards thanks to a set of rules and quality assurance methods known as Good Manufacturing Practices (GMP). Aspects of manufacturing like as infrastructure, equipment, cleanliness, paperwork, personnel training, quality control testing, packaging, labelling, and storage are all covered by GMP laws.

Contamination, batch-to-batch fluctuation, and manufacturing mistakes are reduced when GMP is used. In order to guarantee the safety, effectiveness, and dependability of Ayurvedic medications, certified Ayurvedic pharmaceutical firms must adhere to GMP. WHO guidelines also emphasize assessment of identity, purity, safety, and efficacy of herbal medicines.

Challenges in Scientific Validation: Despite advancements, several challenges remain:

Complexity of Polyherbal Formulations: Multiple ingredients produce synergistic effects that are difficult to standardize.

Variability in Raw Materials: Geographical conditions, harvesting methods, and seasonal variations affect phytochemical composition.

Lack of Standard Marker Compounds: Identification of suitable biomarkers for standardization remains difficult.

Adulteration and Substitution: Intentional or accidental adulteration compromises quality and safety.

Limited Clinical Evidence: Many marketed formulations lack robust clinical trials.

Regulatory Limitations: Uniform global regulatory standards for Ayurvedic medicines are still evolving ^54-56.

CONCLUSION: For Ayurvedic commercial formulations to be safe, effective, high-quality, and widely accepted, they must undergo scientific validation. Modern analytical and pharmacological methods are required to build evidence-based legitimacy, yet traditional Ayurvedic knowledge offers a solid therapeutic basis. Ayurvedic goods may be made more consistent and reliable by thorough standardisation that includes pharmacognostic evaluation, phytochemical screening, chromatographic profiling, toxicological investigations, and clinical validation. The future growth of Ayurveda as an evidence-based healthcare system will depend heavily on the integration of ancient concepts with contemporary scientific approaches.

ACKNOWLEDGEMENT: Nil

CONFLICTS OF INTEREST: Nil

REFERENCES:

1. Bijauliya RK, Alok S, Chanchal DK and Kumar M: A comprehensive review on standardization of herbal drugs. Int J Pharm Sci Res 2017; 8(9): 3663-77. doi: 10.13040/IJPSR.0975-8232.8(9).3663-77.
2. Subhose V, Srinivas P and Narayana A: Basic principles of pharmaceutical science in Ayurvēda. Bul of the Ind Inst of Histof Med 2005; 35(2): 83–92.
3. Pandey MM, Rastogi S and Rawat AK: Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid-Based Complem and Altern Med 2013; 2013: 376327. doi: 10.1155/2013/376327.
4. Gautam A, Kashyap SJ, Sharma PK, Garg VK, Visht S and Kumar N: Identification, evaluation, and standardization of herbal drugs: A review. Der Pharmacia Lettre 2010; 2(6): 302-315.
5. Mukherjee PK and Wahile A: Integrated approaches towards drug development from Ayurveda and other Indian systems of medicine. J of Ethnopharm 2006; 103(1): 25–35. doi: 10.1016/j.jep.2005.09.024.
6. Mashelkar RA: Second World Ayurveda Congress (theme: Ayurveda for the future)—inaugural address: Part III. Evid-Based Complem and Alter Med 2008; 5(4): 367–369. doi: 10.1093/ecam/nen015.
7. Cooper EL: Ayurveda is embraced by eCAM. Evid Based Complem and Alter Med 2008; 5(1): 1–2. doi: 10.1093/ecam/nen016.
8. Kumari R: Standardization of herbal medicines. Int J of Pharma Sci and Res, (2016; 7(2): 100-102.
9. Tripathi B: Sharangdhar Samhita. ChaukhambaSurbharti Prakashan, Varanasi, Edition 1998; Madhyam Khand: 167.
10. Tripathi B: Sharangdhar Samhita. ChaukhambaSurbharti Prakashan, Varanasi, Edition 1998; Madhyam Khand: 133-153.
11. Arote P: Review on Kwatha Kalpana. J of Ayur and Int Med Sci 2020; 5(6): 220-223. doi: 10.21760/jaims.v5i06.1145.
12. Payal: Review on Panchavidha Kashaya Kalpana. Int J of Res in Ind Med 2020; 4(5): 1-6.
13. Kaur H: Importance of various Upkalpana in Ayurvedic therapeutics. IAMJ 2015; 3(7): 2156-2162.
14. Panda P: A review on pharmaceutical and therapeutic uses of Churna (powder) in Ayurveda. International Ayurvedic Medical Journal 2017; 5(11): 4233-4242.
15. Simha GV: Evaluation of standardization parameters for Narasimha Churna an important Ayurvedic formulation. Asian J of Res in Chem 2012; 5(11): 1368-1371.
16. Meena AK: Evaluation of quality control parameters for SrngyadiChurna – A potential Ayurvedic formulation. Res J of Pharmacog and Phytochem 2013; 5(1): 42-46.
17. Johnson DB: Gastroprotective activity of Avipathi Choornam. Research Journal of Pharmacognosy and Phytochemistry 2013; 5(1): 37-41.
18. Panda P: Tablet and tableting in Ayurveda (Vati Kalpana) – A review. IAMJ 2016; 4(7): 1218-1222.
19. Chowdhary Y: Development and evaluation of Dashmula plants of Ayurveda. Asian J of Pharm Tech 2018; 8(1): 08-12. doi: 10.5958/2231-5713.2018.00002.8.
20. The Ayurvedic Formulary of India, Part-I, First Edition. Govt. of India, Ministry of AYUSH, New Delhi 1978: 1.
21. Panda P: Taila Kalpana (medicated oil) in Ayurveda. Research Journal of Pharmacology and Pharmacodynamics 2016; 8(1): 39-41.
22. Swapna E: Evaluation of antioxidant activity of marketed Ayurvedic formulations – Balarishta. Research Journal of Pharmacognosy and Phytochemistry 2015; 7(2): 107-110. doi: 10.5958/0975-4385.2015.00018.7.
23. Patil SG: Standard tools for evaluation of herbal drugs: An overview. The Pharma Innovation Journal 2013; 2(9): 60.
24. WHO: Quality control methods for medicinal plant materials. World Health Organization, Geneva, 1988.
25. Gautam A: Identification, evaluation and standardization of herbal drugs: A review. Der Pharmacia Lettre 2010; 2(6): 302-315.
26. The United States Pharmacopoeia and National Formulary, USP 25 NF 19/National Formulary 20. Rockville, MD, U.S. Pharmacopoeial Convention, Inc. 2002.
27. Pharmacopoeia of the People’s Republic of China, English Edition. The Pharmacopoeia Commission of PRC, Beijing 2000.
28. WHO: Guidelines on good agricultural and collection practices (GACP). World Health Organization, Geneva 2003.
29. Kokate CK, Gokhale SB and Purohit AP: Pharmacognosy. Nirali Prakashan, Pune 2010; 1: 2.
30. Ansari SH: Essentials of Pharmacognosy. Birla Publications Pvt. Ltd. 2011.
31. Gupta MK and Sharma PK: Text Book of Pharmacognosy, Ayurvedic formulations. Pragati Prakashan, Meerut, Vol II, First Edition 2007.
32. Choudhary N and Sekhon BS: An overview of advances in the standardization of herbal drugs. J of Pharm Educ and Res 2011; 2(2).
33. Patil SG: Standard tools for evaluation of herbal drugs: An overview. The Pharm Innov J 2013; 2(9): 60.
34. Liang YZ, Xie P and Chan KJ: Quality control of herbal medicines. Journal of Chromatography B 2004; 812: 53–70.
35. Calixto JB and Barz J: Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J of Med and Biol Res 2000; 33: 179–189.
36. World Health Organization: General guidelines for methodologies on research and evaluation of traditional medicine. Geneva: WHO 2002.
37. European Medicines Agency: Guidelines on quality of herbal medicinal products/traditional medicinal products. London: EMA 2005.
38. Heftmann E: Chromatography: Fundamentals and applications of chromatography and related differential migration methods-Part B: Applications. Amsterdam: Elsevier 2004.
39. Singhal A, Saini U, Chopra B, Dhingra AK, Jain A and Chaudhary J: UV-visible spectroscopy: A review on its pharmaceutical and bio-allied sciences applications. Current Pharmaceutical Analysis 2024; 20(3): 161-177. doi: 10.2174/01157341293005622404080426.
40. Jităreanu A, Trifan A, Vieriu M, Caba IC, Mârțu I and Agoroaei L: Current trends in toxicity assessment of herbal medicines: A narrative review. Processes 2022; 11(1): 83. doi: 10.3390/pr11010083.
41. Ifeoma O and Oluwakanyinsola S: Screening of herbal medicines for potential toxicities. In: Gowder S (Ed.), New insights into toxicity and drug testing. IntechOpen, Rijeka 2013: 63–88. doi: 10.5772/54493.
42. Hamidi MR, Jovanova B, Panovska TK: Toxicity testing using the brine shrimp: Artemia salina. Maced Pharma Bullet 2014; 60(01):9-18. DOI:10.33320/maced.pharm.bull.2014.60.01.002
43. Singh RP and Bansal A: Heavy metal contamination in Ayurvedic medicines: Safety concerns and solutions. J of Env Heal and Tox 2015; 34(6): 1-9. doi: 10.4103/0972-7407.157171.
44. Rathod NB and Pandya S: Ayurvedic medicinal plants: A review of their pharmacological and toxicological profiles. Int J of Ayu Res 2021; 12(4): 101-110. doi: 10.4103/ija.ija_14_21.
45. Gupta A and Misra S: Toxicological evaluation of Ayurvedic formulations: A review. Pharmacog Re 2016; 10(19): 45-52. doi: 10.4103/0973-7847.1892904.
46. Jain PK, Das D, Jain P, Jain P and Jain PK: Pharmacognostic and pharmacological aspect of Bacopa monnieri – A review. Innov J of Ayu Sci 2016; 4: 796-811.
47. Specifications: Test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances (CPMP/ICH/367/96).
48. Reflection paper on stability testing of herbal medicinal products and traditional herbal medicinal products (Ref. EMA/HMPC/3626/2009), adopted 21 October 2010.
49. Dubey N K, Kumar R and Tripathi P. Global promotion of herbal medicine: India. opportunity. Current Sci 2004; 86 (1): 37-41.
50. Ekka NR, Namdeo KP and Samal PK: Standardization strategies for herbal drugs – An overview. Research Journal of Pharmacy and Technology 2008; 1(4): 310-312.
51. Gautam A, Kashyap SJ, Sharma PK, Garg VK, Visht S and Kumar N: Identification, evaluation and standardization of herbal drugs: A review. Der Pharmacia Lettre 2010; 2(6): 302-315.
52. World Health Organization (WHO): Depression. Factsheet. Geneva, Switzerland: WHO 2020.
53. Ahmad Khan MS, Ahmad I and Chattopadhyay D: Herbal medicine: Current trends and future prospects. In: Ahmad Khan MS, Ahmad I and Chattopadhyay D (Eds.), New look to phytomedicine: Advancements in herbal products as novel drug leads. Cambridge: Academic Press 2019: 3–13. doi: 10.1016/B978-0-12-814619-4.00001-X.
54. Wake GE and Fitie GW: Magnitude and determinant factors of herbal medicine utilization among mothers attending antenatal care at public health institutions in Debre Berhan Town, Ethiopia. Frontiers in Public Health 2022; 10: 883053. doi: 10.3389/fpubh.2022.883053.
55. Noor-E-Tabassum, Das R, Lami MS, Chakraborty AJ, Mitra S, Tallei TE, Idroes R, Mohamed AA, Hossain MJ, Dhama K, Mostafa-Hedeab G and Emran TB: Ginkgo biloba: A treasure of functional phytochemicals with multimedicinal applications. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 8288818. doi: 10.1155/2022/8288818.
56. Ibanez B, Melero A, Montoro A, Merino-Torres JF, Soriano JM and San Onofre N: A narrative review of the herbal preparation of Ayurvedic, Traditional Chinese, and Kampō medicines applied as radioprotectors. Antioxidants (Basel) 2023; 12(7): 1437. doi: 10.3390/antiox12071437.
    

    ---

    How to cite this article:

    Kashayap D, Kannojia P and Sharma PK: A comprehensive review: study on scientific validation of ayurvedic marketed formulations. Int J Pharm Sci & Res 2026; 17(10): 2905-14. doi: 10.13040/IJPSR.0975-8232.17(10).2905-14.

    ---

    All © 2026 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.